Singapore biomedical R&D strong despite wider downturn
This article was originally published in Scrip
Executive Summary
The private sector still appears to have faith in the attractions of Singapore as a place to carry out research, at least if the latest official figures are anything to go by. Total business expenditure on R&D in the city-state's biomedical sciences sector rose by 24% last year, to S$527.7 million ($405.9 million).